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What’s Known on This Subject
Stool-withholding behavior is probably the major cause for development and/or per-
sistence of childhood constipation. There is some evidence that the adjunct of behav-
ioral interventions to laxative therapy, rather than laxative therapy alone, improves con-
tinence in children with constipation.
What This Study Adds
This is the ﬁrst large, randomized, controlled trial evaluating the effectiveness of behav-
ioral therapy in constipated children. The study showed that conventional treatment
should remain the ﬁrst choice of treatment. When behavioral problems are present,
behavioral therapy should be considered.
ABSTRACT
OBJECTIVE. It has been suggested that the addition of behavioral interventions to laxa-
tive therapy improves continence in children with functional fecal incontinence
associated with constipation. Our aim was to evaluate the clinical effectiveness of
behavioral therapy with laxatives compared with conventional treatment in treating
functional constipation in childhood.
PATIENTS AND METHODS. In this randomized, controlled trial conducted in a tertiary hos-
pital in the Netherlands, 134 children aged 4 to 18 years with functional constipation
were randomly assigned to 22 weeks (12 visits) of either behavioral therapy or
conventional treatment. Primary outcomes were defecation frequency, fecal incon-
tinence frequency, and success rate. Success was defined as defecation frequency of
3 times per week and fecal incontinence frequency of 1 times per 2 weeks
irrespective of laxative use. Secondary outcomes were stool-withholding behavior
and behavior problems. Outcomes were evaluated at the end of treatment and at
6-months follow-up. All of the analyses were done by intention to treat.
RESULTS.Defecation frequency was significantly higher for conventional treatment.
Fecal incontinence frequency showed no difference between treatments. After 22
weeks, success rates did not differ between conventional treatment and behavioral
therapy (respectively, 62.3% and 51.5%), nor did it differ at 6 months of follow-up
(respectively, 57.3% and 42.3%). The proportion of children withholding stools was not
different between interventions. At follow-up, the proportion of children with behavior
problems was significantly smaller for behavioral therapy (11.7% vs 29.2%).
CONCLUSION.Behavioral therapy with laxatives has no advantage over conventional
treatment in treating childhood constipation. However, when behavior problems are
present, behavioral therapy or referral to mental health services should be
considered.
CONSTIPATION IN CHILDREN is a worldwide problem with a prevalence rangingfrom 0.7% to 29.6%.1 Up to 84% of functional constipated children suffer from
fecal incontinence2 and more than one third exhibit behavior problems.3,4 It remains
unclear whether behavior problems are primary or secondary to functional consti-
pation.
In the vast majority of patients no somatic cause can be found, and, therefore,
these patients are considered to have a functional defecation disorder.5 Retentive
posturing or stool-withholding behavior is probably the major cause for development
and/or persistence of childhood constipation.6–11 Retained stools become progres-
sively more difficult and painful to evacuate, leading to fear and avoidance of defecation.12,13 This vicious cycle can
be described as learned behavior.
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Based on clinical experience, constipated children are
traditionally treated by pediatricians combining laxative
treatment with behavioral approaches, like toilet train-
ing and education. Long-term follow-up studies showed,
however, that despite intensive medical treatment, func-
tional constipation persists into young adulthood in one
third of patients.14,15
In treating childhood constipation, it seems important
to address defecation avoidance and to treat behavior
problems. There is some evidence that the adjunct of
behavioral interventions to laxative therapy, rather than
laxative therapy alone, improves continence in children
with functional fecal incontinence associated with con-
stipation.16–18 We developed a protocolized behavioral
therapy (BT) for constipated children and their parents.
The present study results aimed to evaluate this BT with
laxatives compared with conventional treatment (CT). It
was hypothesized that BT with laxatives would result in
more success regarding constipation, stool-withholding
behavior, and behavior problems.
METHODS
Patients
The study population consisted of children with func-
tional constipation aged 4 to 18 years referred by general
practitioners, school doctors, and pediatricians to the
gastrointestinal outpatient clinic at the Emma Children’s
Hospital. Inclusion took place between November 2002
and August 2004. At entry, patients had to meet at least
2 of 4 criteria: defecation frequency 3 times per week,
fecal incontinence 2 times per week, passage of large
amounts of stool at least once every 7 to 30 days (large
enough to clog the toilet), or a palpable abdominal or
rectal fecal mass.19 Children were excluded if they had
received a comprehensive BT in the previous 12 months.
Children using drugs influencing gastrointestinal func-
tion other than laxatives and children with organic
causes for defecation disorders, such as Hirschsprung dis-
ease, spina bifida occulta, hypothyroidism, or other meta-
bolic or renal abnormalities, were also excluded. The med-
ical ethics committee of the Academic Medical Center of
Amsterdam approved the study protocol. All of the patients
and/or parents gave written informed consent.
Baseline Assessment
One week before baseline assessment the pediatric gas-
troenterologist asked the parents to consider participa-
tion in the study. Parents were assigned to discontinue
any laxative treatment and to record in a bowel diary
frequency of stools and episodes of fecal incontinence.
The criterion of a standard amount of stool was illus-
trated to parents with a clay model. Fecal incontinence
was defined as any amount of feces in the underwear.
The next week eligibility was verified, and a physical
examination, including digital rectal examination, was
performed to evaluate presence of an abdominal or rec-
tal fecal mass. Baseline data for primary and secondary
outcome measures were obtained. The parent who ac-
companied the child to the outpatient clinic filled out the
questionnaire for the secondary outcomes.
Design
The study had a 2-parallel group, randomized, con-
trolled design. After baseline measurement and if writ-
ten informed consent was given, a research assistant
performed a telephone call to a randomization center
and revealed the allocation to parents immediately. A
computer-based system was used to generate a sequence
of random group assignment for consecutive patients.
Random assignment was stratified by age (4–8 years or
8 years) and gender. Within 2 weeks after random as-
signment, patients received their first treatment session.
Intervention
The intervention period for both CT and BT consisted of
12 visits during 22 weeks with similar intervals between
treatment sessions. CT and BT used similar laxative ther-
apy. Disimpaction with daily Klyx enemas (PCH Phar-
machemie BV-Teva Pharmaceutical Industries, Haarlem,
Netherlands, sodium-dioctylsulfosuccinate and sorbitol;
60 mL per day for children 6 years of age; 120 mL per
day for children 6 years of age) for 3 consecutive days
was prescribed by pediatric gastroenterologists before
starting treatment. Maintenance therapy consisted of
polyethylene glycol 3350, 1 sachet (10 g) per day, and if
treatment was considered to have insufficient effect, the
dose was increased by 1 sachet. If spontaneous defeca-
tion was delayed for 3 days, parents were advised to
give an enema or bisacodyl suppository of 5 mg. In BT,
it was preferred to give oral bisacodyl tablets of 5 mg
instead of rectal laxatives. During BT, pediatric psychol-
ogists adjusted the laxative dose and consulted a pediat-
ric gastroenterologist when necessary. In both treatment
groups, patients kept a bowel diary.
CT
CT was conducted by pediatric gastroenterologists and
consisted of visits lasting 20 to 30 minutes, during
which laxative treatment (polyethylene glycol 3350 and,
if necessary, Klyx enemas or bisacodyl suppositories)
and the bowel diary were discussed. Patients and their
parents received education to explain that symptoms are
not harmful and are common in children with func-
tional constipation and that a positive, nonaccusatory
approach is essential.20 Furthermore, children were in-
structed not to withhold stool when they feel urge to
defecate. Motivation was enhanced by praise and small
gifts from the pediatric gastroenterologists.
Protocolized BT
BT was developed by pediatric psychologists of the psy-
chosocial department of our hospital.21 The basic as-
sumption is that phobic reactions related to defecation
can be reduced and that adequate toileting behavior and
appropriate defecation straining can be (re)acquired by
teaching parents behavioral procedures and by behav-
ioral play therapy with the child in presence of his or her
parents. The protocol consists of 2 age-related modules:
a module for children aged 4 to 8 years and a module for
children aged 8 years. The learning process for child
and parents consists of 5 sequential steps: know, dare,
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can, will, and do. This approach is derived from a multi-
disciplinary BT to treat children with defecation disor-
ders.22,23 For all involved psychologists, a detailed manual
for both age-related modules was available to ensure a
standard delivery of therapy. Visits lasted 45 minutes.
Clinical Outcomes
Primary outcome measures were defecation frequency
per week, fecal incontinence frequency per week, and
successful treatment. Treatment was considered success-
ful if patients achieved a defecation frequency of 3
times per week and a fecal incontinence frequency of1
times per 2 weeks, irrespective of laxative use.
Secondary outcome measures were stool-withhold-
ing behavior and behavior problems. Stool-withholding
behavior was scored on a 3-point scale (yes, sometimes,
or no) by asking parents if they observed that their child
holds his legs stiffly together or crosses them when feel-
ing urge to defecate. Behavior problems were assessed
by the Child Behavior Checklist (CBCL/4–18).24 This
questionnaire obtains parent’s report of their child’s be-
havior problems at the time of administration and for
the preceding 6 months. Behavioral ratings were com-
pared with a normative sample of Dutch children.25 The
CBCL yields scores for a total problem scale and for an
internalizing (withdrawal, somatic complaints, and anx-
iety or depression) and externalizing (delinquency and
aggression) behavior problem scale. Derived from stan-
dard scores, a normalized T-score 63 (90th percentile)
is a well-validated cutoff discriminating between nonre-
ferred and referred children to mental health centers. It
indicates whether a child needs professional help for his
or her problems.24
Assessments in each intervention arm took place at
the last visit (posttreatment time point) and 6 months
after the 22-week treatment was ended (follow-up).
Time between baseline assessment and follow-up was
1 year. Follow-up assessment was conducted by tele-
phone by pediatric gastroenterologists. Assessment of
behavior problems at both time points was done by a
research assistant who sent parents one CBCL with a
stamped addressed envelope to return the question-
naire. Parents decided whether the mother or the father
filled out the questionnaire at home.
Sample Size
The sample size was calculated to allow detection of a
25% difference in the proportion of success between BT
and CT. It was estimated that CT reached success in 35%
of the children at follow-up.26 Under the additional as-
sumption of a significance level of .05, a power of .80,
and 2-sided hypothesis testing, a minimal sample size of
124 with 62 children in each group was determined.
Statistical Analysis
Intent-to-treat analyses were conducted using SAS 9.1.3
(SAS Institute, Inc, Cary, NC) and Stata 9.2 (Stata Corp,
College Station, TX). Because of withdrawal before treat-
ment start, dropouts during the study, failure to fill out
questionnaires, or research procedure violations, miss-
ing data occurred. Imputation of missing values was
used to make intent-to-treat analyses feasible.27 Missing
data were imputed using Imputation and Variance Esti-
mation Software (IVEware: Imputation and Variance
Estimation Software, Survey Methodology Program,
Survey Research Center, Institute for Social Research,
University of Michigan. T. E. Raghunathan, Peter W.
Solenberger, John Van Hoewyk), which uses a general-
purpose multivariate imputation procedure (sequential re-
gression imputation method28) that can handle relatively
complex data structures when data aremissing. It produces
imputed values for each individual in the data set condi-
tional on all of the values observed for that individual. In
this manner, 10 different data sets were created. All of the
analyses were performed using these 10 data sets and then
aggregated by averaging the individual results.
Independent sample t tests were used to test differ-
ences in continuous variables and 2 tests when the
variables were categorical for the sample description at
baseline. The proportion of patients who dropped out
before the end of treatment was tabulated and compared
using 2.
To determine the effect of treatment on defecation
frequency and fecal incontinence frequency, negative
binomial regression models were fitted with treatment
(CT or BT), time (posttreatment and follow-up), and
treatment by time as factors. To control for possible
differences in baseline values, defecation or fecal incon-
tinence frequency at baseline were included in the
model as covariates. For these regression models, a ro-
bust variance estimator was used. For all of the binary
outcome measures, a risk ratio model was applied. The
effect of treatment condition on the proportion of suc-
cessfully treated children, stool-withholding behavior,
and CBCL behavior problems (normalized T-score:63)
was derived using generalized linear models for the bi-
nomial family with treatment, time, and treatment-by-
time interaction as factors in the model. Again, baseline
measures were included to control for differences in
baseline values. For stool-withholding behavior and the
3 CBCL scales, the proportion of children at baseline was
included, whereas success rate was adjusted for the base-
line value of defecation and fecal incontinence fre-
quency. Adjusted means and proportions were derived
from the regression models based on their linear predic-
tions. Estimated values (adjusted), rather than observed
(unadjusted) values, are presented throughout the arti-
cle unless otherwise specified. A P value .05 was con-
sidered statistically significant.
RESULTS
Sample
A total of 134 patients were assigned to CT or BT (Fig 1).
During treatment 2 (3.1%) of 64 in the CT group and 9
(13.8%) of 65 in the BT group discontinued intervention
(P  .054). At follow-up, 4 patients dropped out in CT.
There was 1 loss of contact, and 3 children were referred
for BT directly after CT, making them unsuitable for
follow-up measurements. Questionnaires were not re-
turned by 3 patients in both intervention arms at post-
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treatment and by 9 patients (CT: 6; BT: 3) at follow-up.
Baseline characteristics are presented in Table 1. Except
for painful defecation (P  .014), there were no signif-
icant differences found between the 2 groups in socio-
demographic factors or for clinical characteristics.
Primary Outcomes
Baseline data are presented in Table 1. Defecation fre-
quency increased from an average of 2.0 stools per week
to 7.2 in the CT group and 5.4 in the BT group at
posttreatment (Table 2). Compared with the BT group,
defecation frequency in CT was significantly higher (in-
cidence rate ratio: 0.75; 95% confidence interval [CI]:
0.59–0.96; P .021). Planned comparisons showed that
this effect was mainly caused by a difference between
interventions at posttreatment (7.2 vs 5.4; P .021) and
not at follow-up (6.6 vs 5.3; P  .150).
Fecal incontinence frequency dropped from an aver-
age of 15 per week at start of the study to 2.1 and 5.0 per
week at posttreatment for, respectively, CT and BT
(Table 2). From posttreatment to follow-up, fecal in-
continence frequency increased to an average of 6.4 in
CT and 8.6 in BT. There was no statistically significant
difference found between treatment conditions (P 
.135).
At posttreatment, success rate was higher in CT
(62.3%) than in BT (51.5%; Table 2). However, no
statistically significant difference between treatments
was found (P value .249). At follow-up, the number of
children successfully treated declined to 57.3% in CT
and 42.3% in BT. Again, the difference proved statisti-
cally nonsignificant (P  .095).
Secondary Outcomes
Baseline data are presented in Table 1. Stool-withhold-
ing behavior was reduced from baseline to follow-up in
both treatments conditions; from more than two thirds
of the children withholding their stools to 13.8% in CT
146 patients assessed for eligibility  
67 allocated to receive Behavioral 
Therapy 
9 discontinued intervention 
2 other burden in family 
2 treatment required too much 
effort or time 
5 severe behavior problems 
and/or disturbed parent-child 
interaction 
2 discontinued intervention 
1 other burden in family 
1 severe behavior problems 
and/or disturbed parent-child 
interaction 
56 completed 6 months follow-up 58 completed 6 months follow-up 
1 loss of contact 
3 research procedure violations 
134 randomized 
67 allocated to receive conventional 
treatment 
2 did not receive allocated intervention 
1 free of complaints  
1 declined participation 
3 did not receive allocated intervention 
2 free of complaints  
1 declined participation 
56 completed 22 week treatment 62 completed 22 week treatment 
67 included in ITT analysis 67 included in ITT analysis 
65 received behavioral therapy 64 received conventional treatment 
12 excluded 
3 did not meet functional constipation criteria  
8 refused to participate 
1 loss of contact 
FIGURE 1
Patient ﬂowchart.
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and 10.6% in BT at posttreatment (Table 3). The pro-
portion of children with stool-withholding behavior did
not differ between interventions (P  .654).
Most CBCL forms were filled out by mothers
(72.3%), followed by fathers (15.4%) and others
(10.8%; ie, stepmothers and stepfathers). In 59.6% of
the full cases, the same responder filled out the CBCL at
all of the assessment points, with no difference between
the 2 treatment groups (CT: 58.5%; BT: 60.7%; P 
.813). More than one third of the children exhibited
behavior problems (CBCL normalized T-score: 63) at
baseline. At end of treatment, this percentage was
decreased to 22.8% in CT and 21.9% in BT (Table 3).
At follow-up, BT was found to have influenced behav-
ior problems significantly by reducing the proportion
of children with these problems to 11.7% compared
with 29.2% in CT (relative risk: 0.42; 95% CI: 0.18–
0.96; P  .039).
TABLE 1 Baseline Characteristics of Children Allocated to CT or BT
Demographics CT (n 67) BT (n 67) N P
Age, mean (SD), y 6.5 (2.1) 6.9 (2.5) 134 .367
Boys, n (%) 37 (55.2) 39 (58.2) 134 .727
History
Age of onset constipation, mean (SD), y 3.0 (2.0) 2.8 (1.9) 134 .551
Period of treatment, mean (SD), mo 17.1 (19.4) 18.7 (21.7) 129a .673
Positive family history, n (%) 28 (43.8) 33 (50.8) 131a .338
Outcome measures
Defecation frequency per week, mean (SD) 1.9 (2.7) 2.0 (2.3) 134 .961
Fecal incontinence per week, mean (SD) 15.6 (15.9) 15.0 (14.2) 134 .831
Stool-withholding behavior, n (%) 44 (68.8) 43 (67.2) 128a .850
CBCL total score, n (%)b 26 (38.8) 23 (34.3) 133c .591
CBCL internalizing score, n (%)b 25 (37.3) 23 (34.3) 133c .719
CBCL Externalizing score, n (%)b 18 (26.9) 18 (26.9) 133c 1.00
Additional clinical symptomatology
Painful defecation, n (%) 39 (65.0) 28 (43.1) 125a .014
Hard stools, n (%) 19 (32.2) 14 (22.2) 122a .215
Large amount of stool, n (%) 46 (68.7) 45 (67.2) 134 .853
Abdominal pain, n (%) 46 (69.7) 46 (68.7) 133a .897
Day time urinary incontinence, n (%) 12 (17.9) 10 (14.9) 134 .641
Night time urinary incontinence, n (%) 23 (34.3) 19 (28.4) 134 .456
Physical examination
Abdominal scybalous, n (%) 20 (31.3) 22 (35.5) 126d .614
Rectal scybalous, n (%) 27 (49.1) 38 (58.5) 120d .305
a Missing characteristics were unknown to parents.
b Data show the proportion children with CBCL normalized T-score63 (90th percentile).
c One CBCL questionnaire was not ﬁlled out.
d Physical examination is missing because the child was too anxious to perform examination.
TABLE 2 The Effect of Treatment on Primary OutcomeMeasures: Defecation Frequency, Fecal Incontinence Frequency, and the Proportion of
Success
Variable CT BT Groupa Group Timeb
IRR/RR (95% CI) P IRR/RR (95% CI) P
Defecation frequency per week,
mean (95% CI)
IRR 0.75 (0.59–0.96) .021 IRR 1.06 (0.75–1.50) .758
Posttreatmentc 7.2 (6.1–8.5) 5.4 (4.3–6.7)
Follow-upd 6.6 (5.0–8.8) 5.3 (4.4–6.3)
Fecal incontinence per week,
mean (95% CI)
IRR 2.36 (0.77–7.31) .135 IRR 0.57 (0.12–2.61) .467
Posttreatment 2.1 (0.8–5.8) 5.0 (2.1–12.0)
Follow-up 6.4 (3.5–11.7) 8.6 (4.0–18.3)
Success, % (95% CI)
Posttreatment 62.3 (51.1–76.1) 51.5 (39.7–66.9) RR 0.83 (0.60–1.14) .249 — —
Follow-up 57.3 (46.6–70.4) 42.3 (31.8–56.4) RR 0.74 (0.52–1.05) .095 — —
RR indicates relative risk, derived from generalized linear models for the binomial family with group (CT or BT), defecation frequency, and fecal incontinence frequency at baseline as factors in the
model; IRR, incidence rate ratio, derived from negative binomial regression models with group (CT or BT), time (posttreatment or follow-up), the interaction term of group by time as factors, and
baseline score as covariate included in the model.
a Group is the main effect of BT.
b Group time is the interaction effect of BT with measurement at follow-up.
c Posttreatment is the assessment of clinical outcomes at the last treatment visit.
d Follow-up is the assessment of clinical outcomes 6 months after the 22-week treatment was ended.
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The proportion of children with internalizing prob-
lems also declined from an average of 35.8% to 17.3%
and 18.9% for, respectively, CT and BT (Table 3). At
follow-up, this proportion increased in CT but decreased
further in BT (23.4% vs 14.0%). However, no statisti-
cally significant effect was found for the effect of treat-
ment condition (P  .600) or for the influence of BT at
follow-up (P  .156).
The proportion of children exhibiting externalizing
problems changed from an average proportion of 26.9%
to 15.9% in CT and 15.6% in BT at posttreatment (Table
3). Both treatments seemed equally effective in reducing
externalizing problems (P  .990).
DISCUSSION
This study is the first large randomized, controlled trial
evaluating the clinical effectiveness of BT with laxatives
for functional constipation in childhood. The results in-
dicate that this BT with laxatives has no advantage over
CT in treating childhood constipation. Both treatments
decreased fecal incontinence frequency and increased
defecation frequency. However, CT resulted in a higher
defecation frequency than BT. Behavior problems were
common, with more than one third of the participating
children exhibiting these problems. This study shows
that BT is superior in addressing behavior problems in
constipated children.
Our results can only be compared with 1 other ran-
domized, controlled trial18 and 1 quasirandomized trial,29
which also evaluated the effect of an extensive behav-
ioral intervention with laxatives compared with CT.
Borowitz et al18 also found no differences in treatment
success among 3 different treatment modalities: medical
therapy, medical therapy plus enhanced toilet training,
and medical therapy plus enhanced toilet training plus
biofeedback training. Still, the enhanced toilet training
intervention was considered to be more effective, be-
cause more children responded to treatment with de-
creases in fecal incontinence. This latter finding is in
contrast with our outcome. Taitz et al29 investigated in
47 children the additional effect of play therapy with
both a focus on the individual child and on parent-child
interaction. In accordance with our results, their find-
ings indicated that psychotherapeutic elements do not
add to medical treatment, which traditionally already
incorporates behavioral management techniques, such
as toilet training, positive reinforcement, and education.
Our hypothesis that BT would result in more children
ceasing their stool withholding behavior than CT was
not confirmed. The main assumption underlying our
behavior therapy was that fear for defecation perpetu-
ates chronic constipation with stool-withholding behav-
ior as avoidance response. Prescribed laxative treatment
may have caused large improvement of this aberrant
behavior in both interventions. Laxatives facilitate trans-
port and expulsion by softening of stools and, thus, seem
to prevent stool-withholding behavior sufficiently.8,17
CT was associated with more frequent bowel move-
ments per week. Before starting treatment, optimal laxa-
tive dosages were established for each child by the pediatric
gastroenterologists. However, during BT, pediatric psychol-
ogists adjusted laxative dosages and only consulted the
pediatric gastroenterologist when necessary in their opin-
ion. This possibly resulted in prescribing suboptimal dos-
ages and less use of rescue medication. This stresses the
important role for experienced pediatricians in regulating
laxatives, one of the main components in the treatment of
childhood constipation.30
As expected BT relieved more children from coexist-
ing behavior problems. This is not surprising, because
the behavioral protocol aims at decreasing anxiety and
teaches parents behavior modification procedures. Part
TABLE 3 The Effect of Treatment on Secondary OutcomeMeasures: The Proportion of Children
Exhibiting Stool-Withholding Behavior and Behavior Problems (CBCL Total Score>63)
Variable CT BT Groupa Group Timeb
% 95% CI % 95% CI RR (95% CI) P RR (95% CI) P
Stool-withholding behavior 0.77 (0.24–2.46) .654 1.72 (0.43–6.91) .444
Posttreatmentc 13.8 7.3–26.3 10.6 3.7–30.1
Follow-upd 14.2 7.3–27.8 18.7 9.3–37.7
CBCL total scoree 1.04 (0.65–1.68) .863 0.42 (0.18–0.96) .039
Posttreatment 22.8 13.7–37.7 21.9 12.5–38.2
Follow-up 29.2 19.3–44.3 11.7 5.1–26.7
CBCL internalizing scoree 1.16 (0.66–2.03) .600 0.55 (0.24–1.26) .156
Posttreatment 17.3 9.2–32.3 18.9 10.8–33.2
Follow-up 23.4 13.3–41.0 14.0 6.1–31.7
CBCL externalizing scoree 1.00 (0.52–1.90) .990 0.97 (0.40–2.34) .947
Posttreatment 15.9 8.4–30.1 15.6 8.0–30.3
Follow-up 16.4 8.3–32.2 15.6 7.3–33.1
RR indicates relative risk, derived fromgeneralized linearmodels for the binomial family with group (CT or BT), time (posttreatment or follow-up),
the interaction term of group by time, and the proportion of children having stool-withholding behavior or having CBCL total score 63 at
baseline as factors in the model.
a Group is the main effect of behavioral treatment.
b Group time is the interaction effect of behavioral treatment with measurement at follow-up.
c Posttreatment is the assessment of clinical outcomes at the last treatment visit.
d Follow-up is the assessment of clinical outcomes 6 months after the 22-week treatment was ended.
e Proportion children with CBCL normalized T-score63 (90th percentile).
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of the reduction of behavior problems in both treatments
may be explained by normalized behavioral functioning
after successful treatment, because it is assumed that the
social impact of fecal incontinence is mainly responsible
for disturbed behavior in children with functional defe-
cation disorders.31–33 The exact relationship between
functional constipation and behavior problems still re-
mains unclear, as well as the influence of behavior prob-
lems on treatment outcome. Because in this study no
difference in success rate was revealed between the 2
intervention arms, the beneficial effect of BT on behav-
ioral functioning seems not to be (directly) related to the
resolution of constipation-related symptoms.
Some limitations of this study need to be considered.
The visit frequency and duration of treatment of the CT
were made equivalent to that of the BT group to
strengthen the comparison of treatments, which, how-
ever, could also jeopardize generalizing the findings to
general practice. Regardless of high visit frequency and
duration, this did not lead to a higher success rate com-
pared with those studies with 2 to 6 visits in a time
period of 6 months.18,19,26,31,34,35 Generalization of the
findings may also be hampered, because the pediatric
gastroenterologists involved in this study are highly spe-
cialized and experienced in treating chronic constipa-
tion. However, CT in our study was based on the clinical
practice guideline from the North American Society for
Pediatric Gastroenterology, Hepatology, and Nutrition,36
which provides recommendations for the management
of functional constipation by the primary care provider.
These guidelines are generally available and used by
many pediatric gastroenterologists and primary care pro-
viders. Furthermore, primary outcome measures and
stool-withholding behavior were not blindly rated. An-
other limitation was that pediatric psychologists were
partly responsible for laxative treatment in the BT con-
dition, which possibly resulted in differences in laxative
treatment. Despite the aforementioned limitations, we
feel that our study has several strong points, such as a
large sample that approximates the average patient in
primary care settings with no restrictions regarding psy-
chiatric abnormalities. Furthermore, 2 well-controlled
and protocolized specialized treatments were used with
similar frequency of visits and a 6-months follow-up
period. Also, this study showed a low attrition rate.
This randomized, controlled trial showed that BT with
laxatives has no advantage over CT in treating childhood
constipation. CT should remain the first choice of treat-
ment. BT may be considered when children experience
behavior problems concurrently. Quality of care for chron-
ically constipated children may be improved by adding a
behavioral screening to the clinical evaluation of consti-
pated children.13,36 Positive screening should lead to con-
sidering BT or referral to mental health services.
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